Colchicine Approval Took a Huge Toll on CMS
(MedPage Today) -- Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study showed.
The inflation- and rebate-adjusted Medicaid price per pill jumped from $0.24 in 2008 to...
Read more »